Damian deGoa
Direttore/Membro del Consiglio presso LIQUIDIA CORPORATION
Patrimonio netto: 816 900 $ in data 30/06/2024
Profilo
Damian deGoa is currently the Chief Executive Officer & Director at Liquidia Technologies, Inc. and the Director at Liquidia Corp.
Previously, he held the position of Chief Executive Officer & Director at RareGen LLC from 2018 to 2020.
He also served as the Director at Breas Medical AB from 2015 to 2020.
Prior to that, Damian was the Managing Director at PBM Capital Group LLC from 2012 to 2018 and the Head-International Business Development at Perrigo Co. from 2007 to 2012.
Mr. deGoa holds an MBA from DePaul University and an undergraduate degree from the University of Michigan.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
LIQUIDIA CORPORATION
0.09% | 20/06/2024 | 68 075 ( 0.09% ) | 816 900 $ | 30/06/2024 |
Posizioni attive di Damian deGoa
| Società | Posizione | Inizio |
|---|---|---|
| LIQUIDIA CORPORATION | Direttore/Membro del Consiglio | 14/12/2020 |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Amministratore Delegato | 14/12/2020 |
Precedenti posizioni note di Damian deGoa
| Società | Posizione | Fine |
|---|---|---|
RareGen LLC
 RareGen LLC Miscellaneous Commercial ServicesCommercial Services RareGen LLC provides strategy, investment, and commercialization for rare disease pharmaceutical products. The company is headquartered in Durham, NC. | Amministratore Delegato | 01/11/2020 |
Breas Medical AB
 Breas Medical AB Medical SpecialtiesHealth Technology Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Breas Medical AB is a Swedish company that manufactures home respiratory ventilators and sleep apnea products. The company is based in Mölnlycke, Sweden. Breas Medical was acquired by Human Design Medical LLC, a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. from General Electric Co. on February 04, 2014. | Amministratore Delegato | 01/02/2020 |
PBM Capital Group LLC
 PBM Capital Group LLC Investment ManagersFinance PBM Capital Group LLC (PBM Capital Group) is a private equity and venture capital firm founded in 2010 by Paul B. Manning. The firm is headquartered in Charlottesville, Virginia. | Amministratore Delegato | 01/08/2018 |
Perrigo Co.
 Perrigo Co. Pharmaceuticals: MajorHealth Technology Perrigo Co. manufactures, distributes and markets pharmaceutical and nutritional products. The company was founded in 1887 and is headquartered in Allegan, MI. | Corporate Officer/Principal | 01/12/2012 |
Formazione di Damian deGoa
| University of Michigan | Undergraduate Degree |
| DePaul University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LIQUIDIA CORPORATION | Health Technology |
| Aziende private | 5 |
|---|---|
RareGen LLC
RareGen LLC Miscellaneous Commercial ServicesCommercial Services RareGen LLC provides strategy, investment, and commercialization for rare disease pharmaceutical products. The company is headquartered in Durham, NC. | Commercial Services |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
PBM Capital Group LLC
PBM Capital Group LLC Investment ManagersFinance PBM Capital Group LLC (PBM Capital Group) is a private equity and venture capital firm founded in 2010 by Paul B. Manning. The firm is headquartered in Charlottesville, Virginia. | Finance |
Breas Medical AB
Breas Medical AB Medical SpecialtiesHealth Technology Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Breas Medical AB is a Swedish company that manufactures home respiratory ventilators and sleep apnea products. The company is based in Mölnlycke, Sweden. Breas Medical was acquired by Human Design Medical LLC, a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. from General Electric Co. on February 04, 2014. | Health Technology |
Perrigo Co.
Perrigo Co. Pharmaceuticals: MajorHealth Technology Perrigo Co. manufactures, distributes and markets pharmaceutical and nutritional products. The company was founded in 1887 and is headquartered in Allegan, MI. | Health Technology |
- Borsa valori
- Insiders
- Damian deGoa
